Article metrics

Download PDFPDF
P22 An exploratory safety and immunogenicity study of human papillomavirus (HPV16+) immunotherapy VB10.16 in women with high grade cervical intraepithelial neoplasia (HSIL; CIN 2/3)

 

Online download statistics by month:

Online download statistics by month: November 2019 to June 2024

AbstractFullPdf
Nov 20192401
Dec 2019200
Jan 2020700
Feb 20201300
Mar 2020801
Apr 20201800
May 20202800
Jun 20201501
Jul 20201800
Aug 20201200
Sep 20205800
Oct 20203501
Nov 20205701
Dec 20205300
Jan 20213600
Feb 20211000
Mar 20212800
Apr 20211900
May 20211200
Jul 2021300
Sep 2021100
Oct 20212100
Nov 20213900
Dec 20212801
Jan 20222401
Feb 20221600
Mar 20222400
Apr 2022800
May 20228800
Jun 20221701
Jul 20222000
Aug 20229502
Sep 20221800
Oct 20221000
Nov 20224000
Dec 20221600
Jan 20231901
Feb 20231401
Mar 20232800
Apr 2023200
May 20231301
Jun 20231100
Jul 2023800
Aug 2023900
Sep 2023400
Oct 20231000
Nov 20232400
Dec 2023800
Jan 20242400
Feb 20241000
Mar 2024800
Apr 20241500
May 20241400
Jun 20241500
Total1157013